Dr. Sumanta (Monty) Pal of City of Hope Cancer Center discusses the current role of interleukin-2 (IL-2) in the context of many other treatment alternatives for metastatic renal cell carcinoma.
Dr. Sumanta (Monty) Pal of City of Hope Cancer Center discusses the current role of interleukin-2 (IL-2) in the context of many other treatment alternatives for metastatic renal cell carcinoma.
read more
read less
10 years ago
#cancer, #cancergrace, #carcinoma, #cell, #center, #city, #grace, #gracecast, #hope, #il2, #immunotherapy, #kidney, #monty, #of, #pal, #rcc, #renal, #sumanta, #targeted, #therapy
